CO/ANALYTICA

Clarity for complex
analytical challenges.

Independent scientific consulting for pharma, biotech and CRO teams. Investigate unexpected results and decide which experiment comes next.

Expertise

Analytical investigations

Unknown compounds, leachables and drug stability.

Biomarker research

Evidence to prioritise signals for follow-up.

Experimental biology

Molecular assays and mechanism of action.

Explore project questions

Approach

Scientific support that fits
the way your team works.

I work directly with your project lead on a defined part of the study, from planning data acquisition to explaining findings to your client. We agree on the scope, responsibilities and deliverables up front.

How an engagement works

Expertise

Questions I can help answer.

Illustrative project briefs and what you can expect from the work.

Experience in diagnostics

My background includes translating molecular assays into device-based tests and evaluating small molecules as potential diagnostic markers. That experience informs how I assess assay performance and the evidence behind a candidate marker.

Unknown peaks and leachables

Could there be leachables beyond the compounds on your target list?

An untargeted screen can flag unexpected compounds during development. I review the spectra alongside blanks and sample history, then recommend which signals to confirm with a reference standard or targeted analysis. This gives your team time to investigate sources and consider mitigation before a regulatory submission.

Drug levels and stability

The measured drug concentration in plasma falls over time.

I examine the quantification, possible degradation products and effects of the sample matrix. Together we choose a follow-up experiment that can distinguish the competing explanations.

Metabolomics and biomarkers

A discovery study produces hundreds of features. Which are worth following?

I check normalization, group signals that may come from the same compound, and weigh fragmentation evidence alongside biological context. Your team gets a shortlist with the reasoning behind each candidate.

Molecular assay development

An assay performs well on a reference sample but struggles with the intended sample.

I review the controls, sample conditions and sensitivity data with your scientists. We define the change to test in the next prototype and what result would justify moving forward.

Mechanism of action

A compound changes a biological response. Which pathway accounts for it?

I bring functional genetics and biochemistry into the experimental design to test competing mechanisms. Your team can assess the evidence before committing resources to a target.

Working together

From the first question to the client meeting.

Bring me in while shaping a CRO proposal, planning an experiment or interpreting a result your team needs to explain.

  1. Discuss the decision

    We meet with your project lead to review the question, available evidence, constraints and the decision the work needs to support.

  2. Agree the scope

    Your project lead and I review the study design alongside the instruments your team already has. If the work calls for specialist equipment, I can help arrange access. We confirm availability, responsibilities and costs in the statement of work, along with the timeline and deliverables.

  3. Work with the team

    I advise on experimental design and data acquisition, analyse results and discuss emerging findings with your lead at agreed checkpoints.

  4. Report and follow through

    I deliver a written report covering the evidence, its limits and recommended next steps. I present the findings to your team or client and handle agreed revisions and follow-up questions.

Pedro Reis Rodrigues

Founder & scientific consultant

Pedro Reis Rodrigues, PhD

I bring 20 years of experience in analytical chemistry and experimental biology. My background includes diagnostic development and designing lateral flow assays during the COVID-19 pandemic.

I help teams investigate unexpected findings in drug development. Could a contaminant have come from packaging or a material in contact with the product? Could a processing step such as sterilisation have altered the drug compound itself?

In extractables and leachables investigations, I work with your team to trace possible sources. When a change appears after processing, I help assess the evidence for chemical modification and identify what to test next.

Contact

What question is holding up your project?

Tell me what you are trying to decide, what data you have and when you need an answer. You can also request my CV.

Co Analytica

Discuss a project